BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 16213533)

  • 1. Psychopharmacology of the hallucinogenic sage Salvia divinorum.
    Prisinzano TE
    Life Sci; 2005 Dec; 78(5):527-31. PubMed ID: 16213533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A unique natural selective kappa-opioid receptor agonist, salvinorin A, and its roles in human therapeutics.
    Cruz A; Domingos S; Gallardo E; Martinho A
    Phytochemistry; 2017 May; 137():9-14. PubMed ID: 28190678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
    Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvinorin C, a new neoclerodane diterpene from a bioactive fraction of the hallucinogenic Mexican mint Salvia divinorum.
    Valdés LJ; Chang HM; Visger DC; Koreeda M
    Org Lett; 2001 Nov; 3(24):3935-7. PubMed ID: 11720573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist.
    Roth BL; Baner K; Westkaemper R; Siebert D; Rice KC; Steinberg S; Ernsberger P; Rothman RB
    Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11934-9. PubMed ID: 12192085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvinorin A: from natural product to human therapeutics.
    Vortherms TA; Roth BL
    Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human psychopharmacology and dose-effects of salvinorin A, a kappa opioid agonist hallucinogen present in the plant Salvia divinorum.
    Johnson MW; MacLean KA; Reissig CJ; Prisinzano TE; Griffiths RR
    Drug Alcohol Depend; 2011 May; 115(1-2):150-5. PubMed ID: 21131142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From local to global-fifty years of research on Salvia divinorum.
    Casselman I; Nock CJ; Wohlmuth H; Weatherby RP; Heinrich M
    J Ethnopharmacol; 2014 Feb; 151(2):768-83. PubMed ID: 24315983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
    Cunningham CW; Rothman RB; Prisinzano TE
    Pharmacol Rev; 2011 Jun; 63(2):316-47. PubMed ID: 21444610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of nonprohibited hallucinogenic plants: increasing relevance for public health? A case report and literature review on the consumption of Salvia divinorum (Diviner's Sage).
    Bücheler R; Gleiter CH; Schwoerer P; Gaertner I
    Pharmacopsychiatry; 2005 Jan; 38(1):1-5. PubMed ID: 15706458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A reduce inflammation-induced hypermotility in mice.
    Capasso R; Borrelli F; Zjawiony J; Kutrzeba L; Aviello G; Sarnelli G; Capasso F; Izzo AA
    Neurogastroenterol Motil; 2008 Feb; 20(2):142-8. PubMed ID: 17931335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvia divinorum use and phenomenology: results from an online survey.
    Sumnall HR; Measham F; Brandt SD; Cole JC
    J Psychopharmacol; 2011 Nov; 25(11):1496-507. PubMed ID: 20937616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvia divinorum: from Mazatec medicinal and hallucinogenic plant to emerging recreational drug.
    Zawilska JB; Wojcieszak J
    Hum Psychopharmacol; 2013 Sep; 28(5):403-12. PubMed ID: 23794315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
    Piekielna J; Fichna J; Janecka A
    Postepy Biochem; 2012; 58(4):485-91. PubMed ID: 23662442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salvia divinorum and the unique diterpene hallucinogen, Salvinorin (divinorin) A.
    Valdés LJ
    J Psychoactive Drugs; 1994; 26(3):277-83. PubMed ID: 7844657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The plant-derived hallucinogen, salvinorin A, produces kappa-opioid agonist-like discriminative effects in rhesus monkeys.
    Butelman ER; Harris TJ; Kreek MJ
    Psychopharmacology (Berl); 2004 Mar; 172(2):220-4. PubMed ID: 14586540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hallucinogenic herb Salvia divinorum and its active ingredient salvinorin A inhibit enteric cholinergic transmission in the guinea-pig ileum.
    Capasso R; Borrelli F; Capasso F; Siebert DJ; Stewart DJ; Zjawiony JK; Izzo AA
    Neurogastroenterol Motil; 2006 Jan; 18(1):69-75. PubMed ID: 16371085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The hallucinogen derived from Salvia divinorum, salvinorin A, has kappa-opioid agonist discriminative stimulus effects in rats.
    Willmore-Fordham CB; Krall DM; McCurdy CR; Kinder DH
    Neuropharmacology; 2007 Sep; 53(4):481-6. PubMed ID: 17681558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neo-clerodane diterpenes from the hallucinogenic sage Salvia divinorum.
    Shirota O; Nagamatsu K; Sekita S
    J Nat Prod; 2006 Dec; 69(12):1782-6. PubMed ID: 17190459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological activity of salvinorin A, the major component of Salvia divinorum.
    Listos J; Merska A; Fidecka S
    Pharmacol Rep; 2011; 63(6):1305-9. PubMed ID: 22358078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.